Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis

International Journal of Cancer

Volumn 120, Issue 6, 2007, Pages 1223-1231

  Wang, Qiuyu ^a   Kumar, Shant ^b   Mitsios, Nick ^a   Slevin, Mark ^a   Kumar, Patricia ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Isoform; Melanocyte; Microarray; PAX3

Indexed keywords

TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX3A; TRANSCRIPTION FACTOR PAX3B; TRANSCRIPTION FACTOR PAX3C; TRANSCRIPTION FACTOR PAX3D; TRANSCRIPTION FACTOR PAX3E; TRANSCRIPTION FACTOR PAX3F; TRANSCRIPTION FACTOR PAX3G; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CODON; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EXON; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN GENOME PROJECT; INTRON; MELANOCYTE; MICROARRAY ANALYSIS; MOUSE; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; VECTOR CONTROL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MELANOCYTES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIRED BOX TRANSCRIPTION FACTORS; PROTEIN ISOFORMS; RNA, MESSENGER; TRANSFECTION;

EID: 33846986446     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22316     Document Type: Article

References (39)

1. Harris RG, White E, Phillips ES, Lillycrop KA. The expression of the developmentally regulated proto-oncogene Pax-3 is modulated by N-Myc. J Biol Chem 2002;277:34815-25.
2. Tsukamoto K, Nakamura Y, Niikawa N. Isolation of two isoforms of the PAX3 gene transcripts and their tissue-specific alternative expression in human adult tissues. Hum Genet 1994;93:270-4.
3. Barber TD, Barber MC, Cloutier TE, Friedman TB. PAX3 gene structure, alternative splicing and evolution. Gene 1999;237:311-19.
4. Parker CJ, Shawcross SG, Li H, Wang Q, Herrington CS, Kumar S, MacKie RM, Prime W, Rennie IG, Sisley K, Kumar P. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin. Int J Cancer 2004;108:314-20.
5. Macina RA, Barr FG, Galili N, Riethman HC. Genomic organization of the human PAX3 gene: DNA sequence analysis of the region disrupted in alveolar rhabdomyosarcoma. Genomics 1995;26:1-8.
6. Wang Q, Parker C, Kumar S, Kumar P. Differential PAX3 expression in neuroblastoma. In: Park AJ, ed. Proceedings of the 22nd world congress of pathology and laboratory medicine. Medimond S.r.l., 2004. 271-3.
7. Wang Q, Parker C, Kumar S, Kumar P. Functional analysis of alternative isoforms of PAX3 in melanocytes, Melanoma Res 2004;14 (Suppl):26.
8. Pritchard C, Grosveld G, Hollenbach AD. Alternative splicing of Pax3 produces a transcriptionally inactive protein. Gene 2003;305:61-9.
9. Cao Y, Wang C. The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain. J Biol Chem 2000;275:9854-62.
10. Apuzzo S, Gros P. Site-specific modification of single cysteine Pax3 mutants reveals reciprocal regulation of DNA binding activity of the paired and homeo domain. Biochemistry 2002;41:12076-85.
11. Xia SJ, Barr FG. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene 2004;23:6864-71.
12. Epstein JA, Lam P, Jepeal L, Maas RL, Shapiro DN. Pax3 inhibits myogenic differentiation of cultured myoblast cells. J Biol Chem 1995;270:11719-22.
13. Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet 1998;18:283-6.
14. Galibert MD, Yavuzer U, Dexter TJ, Goding CR. Pax.3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J Biol Chem 1999;274:26894-900.
15. Mayanil CS, George D, Freilich L, Miljan EJ, Mania-Farnell B, McLone DG, Bremer EG. Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem 2001;276:49299-309.
16. Kwang SJ, Brugger SM, Lazik A, Merrill AE, Wu LY, Liu YH, Ishii M, Sangiorgi FO, Rauchman M, Sucov HM, Maas RL, Maxson RE, Jr. Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest. Development 2002;129:527-38.
17. Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB. Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma. Genomics 2002;79:278-84.
18. Lamey TM, Koenders A, Ziman M. Pax genes in myogenesis: alternate transcripts add complexity. Histol Histopathol 2004;19:1289-300.
19. Khan J, Simon R, Bittner M, Cheng Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998;58:5009-13.
20. Ye S, Day INM, eds. Microarrays and microplates: applications in biomedical sciences. BIOS Scientific Publishers, 2003.23-43.
21. Du S, Lawrence EJ, Strzelecki D, Rajput P, Xia SJ, Gottesman DM, Barr FG. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transcription properties in rhabdomyosarcoma. Int J Cancer 2005;115:85-92.
22. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-5.
23. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 2003;106:472-9.
24. Begum S, Emani N, Cheung A, Wilkins O, Der S, Hamel PA. Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR. Oncogene 2005;24:1860-72.
25. Heer R, Douglas D, Mathers M, Robson C, Leung H. Fibroblast growth factor 17 is over-expressed in human prostate cancer. J Pathol 2004;204:578-86.
26. Xu J, Lawshe A, MacArthur CA, Ornitz DM. Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech Dev 1999;83:165-78.
27. Wehrle-Haller B. The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res 2003;16:287-96.
28. Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 2000;24:157-62.
29. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995;269:1270-2.
30. Pervaiz S, Cao J, Chao OS, Chin YY, Clement MV. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene 2001;20:6263-8.
31. Adolphe C, Narang M, Ellis T, Wicking C, Kaur P, Wainwright B. An in vivo comparative study of sonic, desert and Indian hedgehog reveals that hedgehog pathway activity regulates epidermal stem cell homeostasis. Development 2004;131:5009-19.
32. Mostowska A, Kobielak A, Trzeciak WH. Molecular basis of non-syndromic tooth agenesis: mutations of MSX1 and PAX9 reflect their role in patterning human dentition. Eur J Oral Sci 2003;111:365-70.
33. Bendall AJ, Ding J, Hu G, Shen MM, Abate-Shen C. Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors. Development 1999;126:4965-76.
34. Brown CB, Engleka KA, Wenning J, Min Lu M, Epstein JA. Identification of a hypaxial somite enhancer element regulating Pax3 expression in migrating myoblasts and characterization of hypaxial muscle Cre transgenic mice. Genesis 2005;41:202-9.
35. Houzelstein D, Auda-Boucher G, Cheraud Y, Rouaud T, Blanc I, Tajbakhsh S, Buckingham ME. Fontaine-Perus J, Robert B. The homeobox gene Msx1 is expressed in a subset of somites, and in muscle progenitor cells migrating into the forelimb. Development 1999;126:2689-701.
36. Cruz J, Reis-Filho JS, Silva P, Lopes JM. Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas. Oncology 2003;65:72-82.
37. Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G, Ruzicka T, Hengge UR. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 2005;141:165-73.
38. Holzmann B, Brocker EB, Lehmann JM, Ruiter DJ, Sorg C, Riethmuller G, Johnson JP. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer 1987;39:466-71.
39. Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 1997;57:3835-40.